ADD CONDITION
Monteban 45
Last content change checked dailysee data sync status
- Active ingredient
- Narasin 100 g/1 kg
- Other brand name
- Dosage form
- Granule
- Route
- Oral
- Prescription status
- Animal
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 2012
- Label revision date
- June 5, 2024
- Veterinary Document
- Prescribing information, PDF file
- Active ingredient
- Narasin 100 g/1 kg
- Other brand name
- Dosage form
- Granule
- Route
- Oral
- Prescription status
- Animal
- CSA schedule
- Not a scheduled drug
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 2012
- Label revision date
- June 5, 2024
- Manufacturer
- Elanco US Inc.
- Registration number
- NADA118980
- NDC root
- 58198-0510
- Veterinary Document
- Prescribing information, PDF file
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
Monteban™ 45 is a type of medication known as a narasin Type A medicated article, produced by Elanco™. It is primarily used in veterinary medicine, particularly in the livestock industry, to promote growth and improve feed efficiency in animals. This medication helps support the overall health and productivity of livestock, ensuring they thrive in their environments.
Uses
It seems that the information provided does not include specific details about the species or the conditions and diseases treated or prevented by the drug. Without this information, I cannot provide a clear summary of the uses. If you have more specific details or another list of uses, please share that, and I would be happy to help rewrite it for you!
Dosage and Administration
To prepare Type C medicated feed using Monteban 45, you'll need to mix specific amounts of the product to create one ton of feed that contains between 54 to 90 grams of narasin (an antibiotic used in animal feed). For example, if you want to include 54 grams of narasin, you would mix in 1.20 pounds of Monteban 45. The amounts vary depending on the desired level of narasin, with 90 grams requiring 2.00 pounds of the product. Before mixing it into the total feed, it's important to create a preblend with 15 to 20 pounds of feed to ensure even distribution.
For Type B medicated feed, the process is similar but involves larger quantities of narasin. You would mix Monteban 45 in amounts ranging from 1,350 grams (30 pounds) to 5,400 grams (120 pounds) to produce one ton of feed. Once prepared, the Type C medicated feed should be given continuously as the only source of nutrition for the animals. This ensures they receive the correct dosage of narasin consistently.
What to Avoid
You should be aware of several important guidelines regarding the use of narasin formulations. First and foremost, do not allow adult turkeys, horses, or other equines to access these products, as ingestion can be fatal. Additionally, narasin is not intended for human use, so please avoid any human consumption.
This medication is classified as a restricted drug in California, meaning it should only be used as directed. It's crucial to never feed narasin undiluted, as this can pose serious risks. Always follow these instructions to ensure safety and proper use.
Side Effects
When handling Monteban, it's important to take safety precautions to avoid any potential harm. You should wear protective clothing, impervious gloves, and a dust mask to minimize exposure. After handling the medication, make sure to wash your hands thoroughly with soap and water. If you accidentally get the medication in your eyes, rinse them immediately with water to prevent irritation.
Please be aware that these precautions are essential for your safety while working with Monteban.
Warnings and Precautions
When handling Monteban, it's important to take safety precautions. Always wear protective clothing, impervious gloves, and a dust mask to avoid any exposure. After handling the medication, wash your hands thoroughly with soap and water. If you accidentally get it in your eyes, rinse them immediately with water.
This medication is classified as a restricted drug in California, so be sure to use it only as directed. If you experience any adverse effects or need more information, don’t hesitate to call for emergency medical help at 1-800-428-4441. If you have any concerns while using this medication, stop taking it and reach out to your doctor for guidance.
Overdose
If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, seek medical help right away.
In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to err on the side of caution when it comes to your health. Remember, timely intervention can make a significant difference.
Pregnancy Use
It’s important to note that this product is not intended for human use. If you are handling Monteban, take precautions to protect yourself by wearing appropriate clothing, gloves, and a dust mask. After handling, wash your hands thoroughly with soap and water. In case of accidental eye contact, rinse your eyes immediately with water.
Additionally, be aware that this product should be stored at or below 25° C (77° F), with limited allowances for temperatures up to 37° C (99° F). Always check the expiration date on the packaging and do not use it past that date. If you are in California, remember that this is a restricted drug and should only be used as directed.
Lactation Use
If you are breastfeeding or planning to breastfeed, it's important to be aware that there is no specific information available regarding the use of this medication during nursing. This means that the effects on breast milk and your nursing infant are not clearly defined.
As always, it's best to consult with your healthcare provider about any medications you are considering while breastfeeding. They can help you weigh the potential risks and benefits to ensure the safety of both you and your baby.
Pediatric Use
It's important to note that this medication is not intended for human use. If you have pets, particularly adult turkeys, horses, or other equines, be very cautious. These animals should not have access to any products containing narasin, as ingestion can be fatal. Always keep such medications securely stored away from animals to prevent any accidental ingestion.
Geriatric Use
When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that the standard dosing guidelines apply, but it’s always important for you or your caregiver to discuss any potential risks or considerations with your healthcare provider.
If you are an older adult or caring for one, staying informed and communicating openly with your doctor can help ensure safe and effective use of the medication. Always report any changes in health or concerns you may have, as these can be important for your overall treatment plan.
Renal Impairment
If you have kidney issues, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations for the medication do not change based on renal impairment. However, it’s always best to discuss your individual situation with your healthcare provider, as they can offer personalized advice and monitor your health closely.
Make sure to keep your doctor informed about your kidney health, as they may need to consider this when prescribing medications or adjusting dosages in the future. Regular check-ups and open communication are key to managing your health effectively.
Hepatic Impairment
If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no tailored recommendations for how the medication may affect you differently due to your liver health.
Always consult your healthcare provider for personalized advice and to ensure that any treatment plan is safe and effective for your specific situation. They can help you understand how to manage your health while considering your liver condition.
Drug Interactions
It's important to be aware of potential interactions when taking medications. For instance, if you are using narasin, you should ensure that adult turkeys, horses, or other equines do not have access to it, as ingestion can be fatal for these animals.
While there are no specific interactions with other drugs or laboratory tests noted, it's always a good practice to discuss all medications and any lab tests you may undergo with your healthcare provider. This helps ensure your safety and the effectiveness of your treatment.
Storage and Handling
To ensure the safety and effectiveness of your product, store it at or below 25° C (77° F). It can briefly be exposed to temperatures up to 37° C (99° F), but try to avoid this whenever possible. Always check the date printed at the top of the bag and do not use the product after this date.
When mixing and handling the product, it's important to wear protective clothing, impervious gloves, and a dust mask to safeguard yourself. After handling, wash your hands thoroughly with soap and water. In case of accidental eye contact, rinse your eyes immediately with water to prevent irritation. Following these guidelines will help you use the product safely and effectively.
Additional Information
You should take Monteban orally. When mixing and handling this medication, it's important to wear protective clothing, impervious gloves, and a dust mask to ensure your safety. After handling, wash your hands thoroughly with soap and water. If you accidentally get the medication in your eyes, rinse them immediately and thoroughly with water.
FAQ
What is Monteban™ 45?
Monteban™ 45 is a narasin Type A medicated article manufactured by Elanco™, with a net weight of 25 kg (55.12 lb).
How should Monteban 45 be mixed for Type C feeds?
For Type C feeds, mix Monteban 45 in amounts ranging from 54 g to 90 g per ton of feed, with a preblend in 15 - 20 lbs of feed before incorporation.
What is the recommended administration method for Type C medicated feed?
Administer the resulting Type C medicated feed continuously as the sole ration.
What precautions should I take when handling Monteban?
When mixing and handling Monteban, use protective clothing, impervious gloves, and a dust mask. Wash thoroughly with soap and water after handling.
What should I do if I accidentally get Monteban in my eyes?
If accidental eye contact occurs, immediately rinse thoroughly with water.
Is Monteban safe for all animals?
No, do not allow adult turkeys, horses, or other equines access to narasin formulations, as ingestion can be fatal.
What is the storage requirement for Monteban?
Store Monteban at or below 25° C (77° F), with excursions permitted to 37° C (99° F).
Is Monteban intended for human use?
No, Monteban is not for human use.
What should I do in case of an emergency related to Monteban?
To report adverse effects or obtain additional product information, call 1-800-428-4441.
Packaging Info
The table below lists each NDC Code for Monteban 45 (narasin) veterinary formulations. Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Granule | 100 g/1 kg | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
Drug Information (PDF)
This PDF provides official product information for Monteban 45, which is intended for animal use only.
Description
Elanco™ Monteban™ 45™ is a narasin Type A medicated article. It is supplied in a net weight of 25 kg (55.12 lb).
Uses and Indications
This drug is indicated for the treatment and prevention of conditions and diseases as determined by healthcare professionals. Specific species and conditions are not detailed in the available information.
Healthcare providers are advised to assess the individual needs of patients to determine the appropriate use of this drug. Further guidance on usage instructions should be obtained from relevant clinical guidelines or product literature.
Dosage and Administration
For the preparation of Type C medicated feed, Monteban 45 should be mixed in specific amounts to achieve a narasin concentration ranging from 54 to 90 grams per ton of feed. The following quantities of Monteban 45 are required for one ton of Type C medicated feed:
54 grams of narasin: 1.20 pounds of Monteban 45
59 grams of narasin: 1.31 pounds of Monteban 45
63 grams of narasin: 1.40 pounds of Monteban 45
68 grams of narasin: 1.51 pounds of Monteban 45
72 grams of narasin: 1.60 pounds of Monteban 45
81 grams of narasin: 1.80 pounds of Monteban 45
90 grams of narasin: 2.00 pounds of Monteban 45
Prior to incorporation into the total amount of finished Type C medicated feed, a preblend of Monteban 45 should be prepared using 15 to 20 pounds of feed.
For the preparation of Type B medicated feed, Monteban 45 should be mixed in the following amounts to manufacture one ton of feed containing up to 5,400 grams of narasin:
1,350 grams of narasin: 30 pounds of Monteban 45
2,700 grams of narasin: 60 pounds of Monteban 45
5,400 grams of narasin: 120 pounds of Monteban 45
The resulting Type C medicated feed should be administered continuously as the sole ration to the intended animals.
Contraindications
Adult turkeys, horses, and other equines must not have access to narasin formulations, as ingestion can be fatal. This product is contraindicated for human use. Additionally, it should not be fed undiluted.
Warnings and Precautions
When mixing and handling Monteban, it is imperative that operators utilize appropriate protective measures. This includes wearing protective clothing, impervious gloves, and a dust mask to minimize exposure. Following handling, operators must wash their hands thoroughly with soap and water. In the event of accidental eye contact, it is crucial to rinse the eyes immediately and thoroughly with water to mitigate potential harm.
Monteban is classified as a restricted drug in California and should be used strictly as directed. Healthcare professionals are advised to ensure that patients understand the importance of adhering to prescribed guidelines.
In case of adverse effects or for additional medical information, healthcare providers and patients should seek emergency medical assistance by calling 1-800-428-4441. It is essential for patients to be informed that they should discontinue use and consult their healthcare provider if they experience any concerning symptoms, although specific instructions for cessation were not provided in the available information.
Side Effects
Patients should be aware of the potential risks associated with the handling of Monteban. It is crucial to use protective clothing, impervious gloves, and a dust mask when mixing and handling this medication. Operators are advised to wash thoroughly with soap and water after handling to minimize exposure. In the event of accidental eye contact, it is imperative to rinse the eyes thoroughly with water immediately.
While specific adverse reactions related to the use of Monteban are not detailed in the provided information, the emphasis on safety precautions highlights the importance of proper handling to prevent potential harm. It is recommended that patients and healthcare providers remain vigilant regarding any adverse effects that may arise during the use of this medication.
Drug Interactions
Ingestion of narasin formulations by adult turkeys, horses, or other equines is contraindicated, as it has been associated with fatal outcomes in these species. Therefore, it is imperative to ensure that these animals do not have access to narasin-containing products to prevent serious adverse effects.
No specific drug or laboratory test interactions have been identified in the available data. As such, routine monitoring for drug interactions is not necessary; however, practitioners should remain vigilant for any unforeseen interactions that may arise in clinical practice.
Packaging & NDC
The table below lists each NDC Code for Monteban 45 (narasin) veterinary formulations. Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Granule | 100 g/1 kg | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
Pediatric Use
Pediatric patients should not be administered narasin, as it is not intended for human use. Caution is advised to prevent access to narasin formulations by adult turkeys, horses, or other equines, as ingestion of narasin by these species has resulted in fatal outcomes.
Geriatric Use
Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.
Pregnancy
Pregnant patients should be aware that this product is not intended for human use. Caution is advised to prevent access to narasin formulations by adult turkeys, horses, or other equines, as ingestion of narasin by these species has been fatal. Due to the potential risks associated with handling this product, operators are recommended to wear protective clothing, impervious gloves, and a dust mask during mixing and handling. It is essential for operators to wash thoroughly with soap and water after handling the product. In the event of accidental eye contact, immediate rinsing with water is necessary.
Storage conditions must be strictly adhered to, with the product stored at or below 25° C (77° F), and excursions permitted only up to 37° C (99° F). The product should not be used after the expiration date printed on the packaging. Additionally, this product is classified as a restricted drug in California and should be used only as directed.
Lactation
There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further data may be necessary to inform clinical decisions.
Renal Impairment
There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.
Hepatic Impairment
Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.
Overdosage
In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.
It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.
In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.
If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.
Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.
Nonclinical Toxicology
Caution should be exercised regarding the access of adult turkeys, horses, or other equines to narasin formulations, as ingestion of narasin by these species has resulted in fatal outcomes. No information is available concerning teratogenic or non-teratogenic effects. Additionally, there is no data provided regarding nonclinical toxicology.
Postmarketing Experience
Adverse effects have been reported voluntarily and through surveillance programs. For inquiries regarding adverse effects, medical information, or additional product information, individuals are encouraged to contact 1-800-428-4441.
Patient Counseling
Healthcare providers should advise patients on the importance of thoroughly mixing the product in feeds before use to ensure proper administration. It is crucial to inform patients that narasin formulations must not be accessible to adult turkeys, horses, or other equines, as ingestion by these species can be fatal.
Providers should emphasize that the product is not intended for human use. When discussing safety precautions, it is important to warn patients that protective clothing, impervious gloves, and a dust mask should be worn while mixing and handling Monteban. Operators must wash their hands thoroughly with soap and water after handling the product. In the event of accidental eye contact, patients should be instructed to rinse their eyes thoroughly with water immediately.
Patients should be informed about the proper storage conditions, which require the product to be kept at or below 25° C (77° F), with permissible excursions up to 37° C (99° F). It is essential to remind patients not to use the product after the expiration date printed at the top of the bag.
For any adverse effects, medical information inquiries, or additional product information, patients should be directed to call 1-800-428-4441.
Storage and Handling
Monteban is supplied in a packaging configuration that includes specific NDC numbers. It should be stored at or below 25° C (77° F), with permissible excursions up to 37° C (99° F).
To ensure safety during mixing and handling, it is essential for operators to wear protective clothing, impervious gloves, and a dust mask. After handling Monteban, operators must wash their hands thoroughly with soap and water. In the event of accidental eye contact, it is crucial to rinse the eyes immediately and thoroughly with water. Additionally, Monteban should not be used after the expiration date printed at the top of the bag.
Additional Clinical Information
The route of administration for the medication is oral. Clinicians should advise patients on the proper handling of Monteban, emphasizing the use of protective clothing, impervious gloves, and a dust mask during mixing and handling. It is important for operators to wash their hands thoroughly with soap and water after handling the medication. In the event of accidental eye contact, immediate rinsing with water is recommended.
Drug Information (PDF)
This document includes the full labeling information for Monteban 45, as submitted by Elanco US Inc. for veterinary use. It may include dosage by species, withdrawal periods, and administration instructions.